{"url_path":"/sec/rnac/8-k/2026-06-09/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1453687/0001140361-26-024556-index.html","accession_number":"0001140361-26-024556","cik":"0001453687","ticker":"RNAC","issuer_name":"Cartesian Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1453687/0001140361-26-024556-index.html","primary_entity_key":"0001453687","primary_entity_name":"Cartesian Therapeutics, Inc."},"word_count":90,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit No.\n\n \n\nExhibit Description\n\n \n\n \n\n \n\n99.1\n\n \n\n[Press release of\nCartesian Therapeutics, Inc. issued on June 9, 2026.](ef20075770_ex99-1.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its\nbehalf by the undersigned hereunto duly authorized.\n\nCARTESIAN THERAPEUTICS\n\nDate: June 9, 2026\n\nBy:\n\n/s/ Carsten Brunn, Ph.D.\n\nCarsten Brunn, Ph.D.\n\nPresident, Chief Executive Officer and Chairman of the Board"}